AR052314A1 - TIENOPIRIDINONE COMPOUNDS AS 5-HT4 RECEIVER AGONISTS - Google Patents
TIENOPIRIDINONE COMPOUNDS AS 5-HT4 RECEIVER AGONISTSInfo
- Publication number
- AR052314A1 AR052314A1 ARP050104240A ARP050104240A AR052314A1 AR 052314 A1 AR052314 A1 AR 052314A1 AR P050104240 A ARP050104240 A AR P050104240A AR P050104240 A ARP050104240 A AR P050104240A AR 052314 A1 AR052314 A1 AR 052314A1
- Authority
- AR
- Argentina
- Prior art keywords
- isopropyl
- disease
- agonists
- ethyl
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Abstract
Se refiere a agonistas y agonistas parciales del receptor 5-HT4. Se describen compuestos de tienopiridinona, y la síntesis y utilizacion de los mismos para tratar enfermedades mediadas directa o indirectamente por los receptores 5-HT4. Dichas condiciones incluyen a la enfermedad de Alzheimer, trastornos cognoscitivos, síndrome de colon irritable, enfermedad de Parkinson, nauseas, émesis, vomitos, pro-quinesia, enfermedad de reflujo gastroesofágico y dispepsia no ulcerosa. También se incluyen los métodos para la preparacion y nuevos intermediarios y sales farmacéuticas de los mismos. Reivindicacion 1: Un compuesto que tiene la formula (1), caracterizado porque: R1 es etilo o isopropilo; y R2 es un grupo alquilo opcionalmente sustituido seleccionado del grupo que consiste en etilo, n-propilo, isopropilo, n-isopropilo, n-butilo, isotubilo, secbutilo, pentilo, metilciclopropilo, isopropanol, feniletilo; y las sales y/o ésteres farmacéuticamente aceptables el mismo.It refers to agonists and partial agonists of the 5-HT4 receptor. Thienopyridinone compounds are described, and the synthesis and use thereof to treat diseases directly or indirectly mediated by 5-HT4 receptors. Such conditions include Alzheimer's disease, cognitive disorders, irritable bowel syndrome, Parkinson's disease, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease and non-ulcer dyspepsia. Methods for the preparation and new intermediates and pharmaceutical salts thereof are also included. Claim 1: A compound having the formula (1), characterized in that: R1 is ethyl or isopropyl; and R2 is an optionally substituted alkyl group selected from the group consisting of ethyl, n-propyl, isopropyl, n-isopropyl, n-butyl, isotubyl, secbutyl, pentyl, methylcyclopropyl, isopropanol, phenylethyl; and pharmaceutically acceptable salts and / or esters thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/960,769 US7407966B2 (en) | 2004-10-07 | 2004-10-07 | Thienopyridinone compounds and methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052314A1 true AR052314A1 (en) | 2007-03-14 |
Family
ID=35594017
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050104240A AR052314A1 (en) | 2004-10-07 | 2005-10-07 | TIENOPIRIDINONE COMPOUNDS AS 5-HT4 RECEIVER AGONISTS |
Country Status (18)
Country | Link |
---|---|
US (1) | US7407966B2 (en) |
EP (1) | EP1802631A2 (en) |
JP (1) | JP2008515907A (en) |
KR (1) | KR20070106682A (en) |
CN (1) | CN101061123A (en) |
AR (1) | AR052314A1 (en) |
AU (1) | AU2005294329A1 (en) |
BR (1) | BRPI0516130A (en) |
CA (1) | CA2583353A1 (en) |
IL (1) | IL182436A0 (en) |
MA (1) | MA29211B1 (en) |
MX (1) | MX2007004230A (en) |
NO (1) | NO20072348L (en) |
NZ (1) | NZ554927A (en) |
RU (1) | RU2007116950A (en) |
TW (1) | TW200621245A (en) |
WO (1) | WO2006041985A2 (en) |
ZA (1) | ZA200703596B (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7968538B2 (en) | 2005-01-25 | 2011-06-28 | Galenea Corp. | Substituted arylamine compounds and methods of treatment |
US20060252830A1 (en) * | 2005-05-06 | 2006-11-09 | Brandon Stephen F | Method for the treatment of magnesium and potassium deficiencies |
US20060252831A1 (en) * | 2005-05-06 | 2006-11-09 | Christopher Offen | Method for the treatment of magnesium and potassium deficiencies |
US8114894B2 (en) * | 2008-12-03 | 2012-02-14 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
SG178557A1 (en) * | 2009-09-14 | 2012-03-29 | Suven Life Sciences Ltd | L -dihydro-2-oxoquinoline compounds a 5-ht4 receptor ligands |
JP2014076948A (en) * | 2011-02-09 | 2014-05-01 | Astellas Pharma Inc | Isoquinoline amide derivative |
EP2679591A1 (en) * | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridone derivatives useful as activators of AMPK |
US9381199B2 (en) | 2012-07-09 | 2016-07-05 | Hetero Research Foundation | Linagliptin solid dispersion |
EP3628660A1 (en) * | 2018-09-28 | 2020-04-01 | Université de Caen Normandie | Donecopride and flucopride as neuroprotective agents in the treatment of neurodegenerative diseases |
WO2023135508A1 (en) * | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | PYRROLO[1,2-b]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3069412A (en) | 1958-08-15 | 1962-12-18 | Fmc Corp | N-aminoazetidine and preparation thereof |
CA933923A (en) | 1969-12-19 | 1973-09-18 | Eichenberger Kurt | Process for the manufacture of new thiopyranes |
GB1570494A (en) | 1975-11-28 | 1980-07-02 | Ici Ltd | Thienopyrimidine derivatives and their use as pesticides |
DE2925175A1 (en) | 1979-06-22 | 1981-01-08 | Basf Ag | METHOD FOR PRODUCING ISATOIC ACID ANHYDRIDES |
IT1203323B (en) | 1987-02-02 | 1989-02-15 | Hoechst Italia Spa | PHOTO-ACTIVATOR ADDITIVE FOR POLYMERIC COMPOSITIONS CONSTITUTED BY METALLIC SALT OF AN OXIDIZED WAX |
US5236917A (en) | 1989-05-04 | 1993-08-17 | Sterling Winthrop Inc. | Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
US5155115A (en) * | 1991-03-12 | 1992-10-13 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5219864A (en) | 1991-03-12 | 1993-06-15 | Kyowa Hakko Kogyo Co., Ltd. | Thienopyridine derivatives |
US5227387A (en) | 1991-09-03 | 1993-07-13 | Dowelanco | Quinoline nematicidal method |
DE4138820A1 (en) | 1991-11-26 | 1993-05-27 | Basf Ag | CHINOLIN-3-CARBONATEAMIDE, THEIR PREPARATION AND USE |
DE4208254A1 (en) | 1992-03-14 | 1993-09-16 | Hoechst Ag | SUBSTITUTED PYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A PEST CONTROL AND FUNGICIDE |
DE4227747A1 (en) | 1992-08-21 | 1994-02-24 | Basf Ag | Heteroaromatically condensed hydroxypyridonecarboxamides, their preparation and use |
US5409948A (en) | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
JPH06239858A (en) | 1993-02-16 | 1994-08-30 | Otsuka Pharmaceut Co Ltd | Peripheral vasodilator |
GB9306460D0 (en) | 1993-03-29 | 1993-05-19 | Smithkline Beecham Plc | Novel compounds |
JPH07324087A (en) * | 1994-04-04 | 1995-12-12 | Taisho Pharmaceut Co Ltd | Heterocyclic compound |
TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
JP3829879B2 (en) | 1994-05-18 | 2006-10-04 | 大正製薬株式会社 | Quinoline carboxylic acid derivatives |
GB2295387A (en) | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
DE19636769A1 (en) | 1996-09-10 | 1998-03-12 | Basf Ag | 3-Substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use |
DE19724980A1 (en) | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use |
JPH11130777A (en) | 1997-08-13 | 1999-05-18 | Takeda Chem Ind Ltd | Thienopyridine derivative, its intermediate and their production |
ATE404539T1 (en) * | 1997-10-02 | 2008-08-15 | Eisai R&D Man Co Ltd | CONDENSED PYRIDINE DERIVATIVES |
AU2879799A (en) * | 1998-02-26 | 1999-09-15 | Neurogen Corporation | 4-(4-piperidylmethylamino) substituted heteroaryl fused pyridines: gaba brain receptor ligands |
DE19815026A1 (en) | 1998-04-03 | 1999-10-07 | Hoechst Schering Agrevo Gmbh | Substituted piperidines, processes for their preparation and their use as pesticides and fungicides |
US6232320B1 (en) * | 1998-06-04 | 2001-05-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory compounds |
WO2000064441A2 (en) | 1999-04-28 | 2000-11-02 | Respiratorius Ab | Compound for use as a medicament for treatment of disorders involving bronchocontraction |
SE9902987D0 (en) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
CA2386163A1 (en) | 1999-10-01 | 2001-04-12 | Masanori Tobe | Novel quinazoline derivatives |
US20040224927A1 (en) | 2000-06-16 | 2004-11-11 | Trustees Of Tufts College | 7-N-substituted phenyl tetracycline compounds |
FR2821356A1 (en) * | 2001-02-23 | 2002-08-30 | Cerep | NOVEL ARYLCARBAMATE AND ARYLUREES DERIVATIVES, PREPARATIONS AND USES |
EP1270568A1 (en) | 2001-06-19 | 2003-01-02 | Biofrontera Pharmaceuticals AG | 1-methyl-4-(3-ethoxy-9h-thioxanthene-ylidene)-piperidine and its use as 5-HT2B and/or H1 antagonist |
WO2003020728A1 (en) * | 2001-08-30 | 2003-03-13 | Pharmacia & Upjohn Company | 4-THIOXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOTHIOAMIDES AS ANTIVIRAL AGENTS |
MXPA03000145A (en) | 2002-01-07 | 2003-07-15 | Pfizer | Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators. |
WO2004034963A2 (en) | 2002-05-17 | 2004-04-29 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
US20040138238A1 (en) | 2002-08-08 | 2004-07-15 | Dhanoa Dale S. | Substituted aminopyrimidine compounds as neurokinin antagonists |
AU2003255845A1 (en) | 2002-08-22 | 2004-03-11 | Piramed Limited | Phosphadidylinositol 3,5-biphosphate inhibitors as anti-viral agents |
AU2003277215A1 (en) | 2002-10-01 | 2004-04-23 | Predix Pharmaceuticals Holdings, Inc. | Novel neurokinin antagonists and methods of use thereof |
US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
WO2004089312A2 (en) | 2003-03-31 | 2004-10-21 | Predix Pharmaceuticals Holdings, Inc. | New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
US20050222175A1 (en) | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7612078B2 (en) | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7119205B2 (en) * | 2003-05-16 | 2006-10-10 | Abbott Laboratories | Thienopyridones as AMPK activators for the treatment of diabetes and obesity |
CN1856312A (en) | 2003-07-25 | 2006-11-01 | 弗·哈夫曼-拉罗切有限公司 | Combination of mGluR2 antagonist and AChE inhibitor for treatment of acute and/or chronic neurological disorders |
GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
CA2544573A1 (en) | 2003-11-03 | 2005-06-02 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US20060084806A1 (en) | 2004-07-21 | 2006-04-20 | Ramasubramanian Sridharan | Processes for the preparation of imidazo[1,2-a] pyridine derivatives |
US7407966B2 (en) | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7576211B2 (en) | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
US7968538B2 (en) | 2005-01-25 | 2011-06-28 | Galenea Corp. | Substituted arylamine compounds and methods of treatment |
JP2009520688A (en) | 2005-11-23 | 2009-05-28 | エピックス デラウェア, インコーポレイテッド | S1P receptor modulating compounds and uses thereof |
-
2004
- 2004-10-07 US US10/960,769 patent/US7407966B2/en active Active
-
2005
- 2005-10-06 MX MX2007004230A patent/MX2007004230A/en unknown
- 2005-10-06 CN CNA2005800391979A patent/CN101061123A/en active Pending
- 2005-10-06 BR BRPI0516130-4A patent/BRPI0516130A/en not_active IP Right Cessation
- 2005-10-06 JP JP2007535801A patent/JP2008515907A/en active Pending
- 2005-10-06 EP EP05801809A patent/EP1802631A2/en not_active Withdrawn
- 2005-10-06 RU RU2007116950/04A patent/RU2007116950A/en not_active Application Discontinuation
- 2005-10-06 WO PCT/US2005/035935 patent/WO2006041985A2/en active Application Filing
- 2005-10-06 NZ NZ554927A patent/NZ554927A/en unknown
- 2005-10-06 CA CA002583353A patent/CA2583353A1/en not_active Abandoned
- 2005-10-06 KR KR1020077008043A patent/KR20070106682A/en not_active Application Discontinuation
- 2005-10-06 AU AU2005294329A patent/AU2005294329A1/en not_active Abandoned
- 2005-10-07 TW TW094135236A patent/TW200621245A/en unknown
- 2005-10-07 AR ARP050104240A patent/AR052314A1/en unknown
-
2007
- 2007-04-10 IL IL182436A patent/IL182436A0/en unknown
- 2007-05-04 ZA ZA200703596A patent/ZA200703596B/en unknown
- 2007-05-04 MA MA29866A patent/MA29211B1/en unknown
- 2007-05-07 NO NO20072348A patent/NO20072348L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2006041985A2 (en) | 2006-04-20 |
AU2005294329A1 (en) | 2006-04-20 |
IL182436A0 (en) | 2007-07-24 |
NZ554927A (en) | 2009-07-31 |
RU2007116950A (en) | 2008-11-20 |
BRPI0516130A (en) | 2008-08-26 |
ZA200703596B (en) | 2008-05-28 |
EP1802631A2 (en) | 2007-07-04 |
CN101061123A (en) | 2007-10-24 |
KR20070106682A (en) | 2007-11-05 |
MX2007004230A (en) | 2007-06-11 |
JP2008515907A (en) | 2008-05-15 |
US7407966B2 (en) | 2008-08-05 |
TW200621245A (en) | 2006-07-01 |
AU2005294329A2 (en) | 2006-04-20 |
MA29211B1 (en) | 2008-02-01 |
NO20072348L (en) | 2007-07-06 |
US20060079547A1 (en) | 2006-04-13 |
WO2006041985A3 (en) | 2006-07-06 |
CA2583353A1 (en) | 2006-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR052314A1 (en) | TIENOPIRIDINONE COMPOUNDS AS 5-HT4 RECEIVER AGONISTS | |
PE20220143A1 (en) | GLP-1R AGONISTS AND USES THEREOF | |
ES2579830T3 (en) | Diaminopyrimidine derivatives and procedures for their preparation | |
PE20121640A1 (en) | PIRAZINE DERIVATIVES AS BACE INHIBITORS | |
AR041302A1 (en) | IMIDAZOPIRIDINE COMPOUNDS AS RECEIVER AGONISTS 5- HT4 AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH COMPOUNDS | |
AR054024A1 (en) | PIRIDINE DERIVATIVES -3- CARBOXAMIDE AS INVESTED AGONISTS OF CB1 | |
CA2900308C (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity | |
PE20061096A1 (en) | OXYINDOL DERIVATIVES AS 5-HT4 AGONISTS | |
AR072952A1 (en) | 2-IMINO-3-METHYL-PIRROLOPIRIMIDINONA PHENYL-REPLACED COMPOUNDS AS BACE-1 INHIBITORS, COMPOSITIONS AND THEIR USE | |
PE20071009A1 (en) | COMPOUNDS DERIVED FROM PHENOXIPIPERIDINES AS ANTAGONISTS OF HISTAMINE H3 | |
NO20065814L (en) | Thiendopyridinone compounds and methods of treatment | |
AR047098A1 (en) | ARILANILINE DERIVATIVES AS BETA2 ADRENERGIC RECEIVER AGONISTS | |
PE20050465A1 (en) | QUINUCLIDINE DERIVED COMPOUNDS AS ANTAGONISTS OF THE MUSCARINE M3 RECEPTOR | |
AR054560A1 (en) | SPIROPIPERIDINE AS BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
PE20060777A1 (en) | INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES | |
PE20110409A1 (en) | HETEROCYCLIC ANTIVIRIC COMPOUNDS | |
AR073574A1 (en) | HETEROCICLIC INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF A DISEASE | |
UY28961A1 (en) | BENCIMIDAZOLONA CARBOXYL ACID DERIVATIVES BACKGROUND OF THE INVENTION | |
EA201591078A1 (en) | PEPTIDES AS AN OXYTOCINE AGONISTS | |
JP6458028B2 (en) | Novel derivatives of indole and pyrrole, processes for their preparation and pharmaceutical compositions containing them | |
AR050281A1 (en) | DERIVATIVES OF INDOL, INDAZOL AND INDAZOLINA. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS | |
CA2770724A1 (en) | 5-ht inhibiting indole compounds | |
EA200701588A1 (en) | METHODS OF OBTAINING SUBSTITUTED PHYLPYRAZOLMOCHEVINS | |
EA200702612A1 (en) | COMPOUNDS OF BENZIMIDAZOZOLKARBOXAMIDE AS AGONISTS OF 5-HT RECEPTORS | |
AR071323A1 (en) | HETEROCICLIC DERIVATIVES OF GLUCOQUINASE ACTIVATING PYRIDAZINONES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, METHOD OF PREPARATION AND USE OF THE SAME IN THE TREATMENT OF MELLITUS TYPE II DIABETES. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |